RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021
RXIIW
RXIIW was delisted on the 16th of November, 2018.
5 hedge funds and large institutions have $1.82M invested in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and closing their positions.
114% more capital invested
Capital invested by funds: $850K → $1.82M (+$966K)
25% more funds holding
Funds holding: 4 → 5 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$428K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$31.7K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$23K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$378 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AFM
1
Anson Funds Management
Dallas,
Texas
| $1.07M | +$428K | +2,222,222 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $375K | -$378 | -1,967 | -0.1% |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $355K | -$23K | -119,695 | -5% |
|
|
4
Hudson Bay Capital Management
Stamford,
Connecticut
| $14K | -$31.7K | -164,557 | -66% |
|
|
LTFS
5
Ladenburg Thalmann Financial Services
Miami,
Florida
| $5K | – | – | – |
|
RXIIW Hedge Fund Activity: Q3 2017 in Review
5 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) for Q3 2017, worth a combined $1.82M — up 114% from $850K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new RXIIW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $428K. The largest seller was Hudson Bay Capital Management, cutting an estimated $31.7K.
- 5 institutional investors held RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) as of Q3 2017, up from 4 in Q2 2017.
- Funds reported $1.82M of RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 stock for Q3 2017, up 114% quarter-over-quarter.
- 1 fund opened new RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 positions in Q3 2017 and 0 closed out, a net change of +1 holder.
- The largest RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 buyer in Q3 2017 was Anson Funds Management, an estimated $428K added.
- The largest RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 seller in Q3 2017 was Hudson Bay Capital Management, an estimated $31.7K sold.
Based on aggregated 13F filings for Q3 2017.